Investing Profile

Derek DiRocco

InvestorVC
Partner at RA Capital Management
racap.comBoston, Massachusetts
Photo of Derek DiRocco, Partner at RA Capital Management

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Medical School Network
52 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
cb
$100K - $5.0M
$1.5M
21
$308.2M
CompanyStageDateRound SizeTotal Raised
Stipple Bio
Series AApr 2026$100M
$100M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Thilo Schroeder (Nextech Invest)
Bambusa Therapeutics
Series ANov 2025
Series AFeb 2025$90M
$90M
Evommune
Series COct 2024$120M
$260M
Co-investors: Ash Khanna (Pivotal bioVenture Partners), Rob Hopfner (Pivotal bioVenture Partners), Mark Chin (Jmi Equity)
Idrx
Series BAug 2024$120M
$120M
Frontier Medicines
Series CFeb 2024$80M
Series BJul 2021$89M
$170M
Co-investors: Paul Stoffels (Johnson & Johnson Innovation)
Mineralys Therapeutics
Post Ipo EquityFeb 2024$120M
Series BJun 2022$120M
$240M
Co-investors: Joël Jean-Mairet (Ysios Capital), Olivier Litzka (Andera Partners)
Carmot Therapeutics
Series EMay 2023$150M
Series DJul 2022$160M
$370M
Co-investors: Peter Svennilson (The Column Group), Zachary Hargreaves (The Founders Fund)
Rivus Pharmaceuticals
Series BSep 2022$130M
$130M
Research Technician Massachusetts General HospitalPresent
Graduate Student - Pharmacology UW MedicinePresent
Post-doctoral Research Fellow Harvard Medical SchoolPresent
Associate RA Capital ManagementPresent
Analyst RA Capital ManagementPresent
Principal RA Capital ManagementPresent
Director 89bioPresent
Board Observer Peloton TherapeuticsPresent
Board Observer Frontier MedicinesPresent
Board Observer VaxcytePresent
Director ITeos TherapeuticsPresent
Director Werewolf TherapeuticsPresent
Board Observer Interius BioTherapeuticsPresent
Director Frontier MedicinesPresent
Director Acrivon Therapeutics, Inc.Present
Director Mineralys Therapeutics, Inc.Present
Board Observer Carmot Therapeutics, Inc.Present
Director Rivus PharmaceuticalsPresent
Director Forward Therapeutics, Inc.Present
Director IDRxPresent
Board Observer Navigator Medicines, Inc.Present
Director EvommunePresent
Director Peloton TherapeuticsPresent
Partner RA Capital ManagementPresent
College of the Holy Cross B.A. Biology
University of Washington School of Medicine PhD Pharmacology
University of Washington - School of Medicine PhD Pharmacology